165 related articles for article (PubMed ID: 36897130)
1. Postpartum Opportunistic Salpingectomy Compared With Bilateral Tubal Ligation After Vaginal Delivery for Ovarian Cancer Risk Reduction: A Cost-Effectiveness Analysis.
Wagar MK; Forlines GL; Moellman N; Carlson A; Matthews M; Williams M
Obstet Gynecol; 2023 Apr; 141(4):819-827. PubMed ID: 36897130
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of opportunistic salpingectomy vs tubal ligation at the time of cesarean delivery.
Venkatesh KK; Clark LH; Stamilio DM
Am J Obstet Gynecol; 2019 Jan; 220(1):106.e1-106.e10. PubMed ID: 30170036
[TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of opportunistic salpingectomy versus standard tubal ligation at the time of cesarean delivery for ovarian cancer risk reduction.
Subramaniam A; Einerson BD; Blanchard CT; Erickson BK; Szychowski J; Leath CA; Biggio JR; Huh WK
Gynecol Oncol; 2019 Jan; 152(1):127-132. PubMed ID: 30477808
[TBL] [Abstract][Full Text] [Related]
4. The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage.
Naumann RW; Hughes BN; Brown J; Drury LK; Herzog TJ
Am J Obstet Gynecol; 2021 Oct; 225(4):397.e1-397.e6. PubMed ID: 33798477
[TBL] [Abstract][Full Text] [Related]
5. Paradigm shift from tubal ligation to opportunistic salpingectomy at cesarean delivery in the United States.
Mandelbaum RS; Matsuzaki S; Sangara RN; Klar M; Matsushima K; Roman LD; Paulson RJ; Wright JD; Matsuo K
Am J Obstet Gynecol; 2021 Oct; 225(4):399.e1-399.e32. PubMed ID: 34181896
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention.
Dilley SE; Havrilesky LJ; Bakkum-Gamez J; Cohn DE; Michael Straughn J; Caughey AB; Rodriguez MI
Gynecol Oncol; 2017 Aug; 146(2):373-379. PubMed ID: 28577884
[TBL] [Abstract][Full Text] [Related]
7. Benefits and Risks of Bilateral Salpingectomy Compared With Standard Tubal Ligation During Cesarean Delivery for Permanent Postpartum Contraception.
Luke S; Addae-Konadu K; Davidson B; Kuller J; Dotters-Katz S
Obstet Gynecol Surv; 2022 Mar; 77(3):167-173. PubMed ID: 35275215
[TBL] [Abstract][Full Text] [Related]
8. Postpartum Salpingectomy Compared With Standard Tubal Ligation After Vaginal Delivery.
Wagar MK; Godecker A; Landeros MV; Williams M
Obstet Gynecol; 2021 Mar; 137(3):514-520. PubMed ID: 33595245
[TBL] [Abstract][Full Text] [Related]
9. Postpartum Permanent Sterilization: Could Bilateral Salpingectomy Replace Bilateral Tubal Ligation?
Danis RB; Della Badia CR; Richard SD
J Minim Invasive Gynecol; 2016; 23(6):928-32. PubMed ID: 27234430
[TBL] [Abstract][Full Text] [Related]
10. Costs and benefits of opportunistic salpingectomy as an ovarian cancer prevention strategy.
Kwon JS; McAlpine JN; Hanley GE; Finlayson SJ; Cohen T; Miller DM; Gilks CB; Huntsman DG
Obstet Gynecol; 2015 Feb; 125(2):338-345. PubMed ID: 25568991
[TBL] [Abstract][Full Text] [Related]
11. Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada.
Hanley GE; Kwon JS; Finlayson SJ; Huntsman DG; Miller D; McAlpine JN
Am J Obstet Gynecol; 2018 Aug; 219(2):172.e1-172.e8. PubMed ID: 29852159
[TBL] [Abstract][Full Text] [Related]
12. The Role of Opportunistic Bilateral Salpingectomy vs Tubal Occlusion or Ligation for Ovarian Cancer Prophylaxis.
Ely LK; Truong M
J Minim Invasive Gynecol; 2017; 24(3):371-378. PubMed ID: 28087480
[TBL] [Abstract][Full Text] [Related]
13. Complete salpingectomy versus tubal ligation during cesarean section: a systematic review and meta-analysis.
Yang M; Du Y; Hu Y
J Matern Fetal Neonatal Med; 2021 Nov; 34(22):3794-3802. PubMed ID: 31752570
[TBL] [Abstract][Full Text] [Related]
14. The Cost-Effectiveness of Salpingectomies for Family Planning in the Prevention of Ovarian Cancer.
Tai RWM; Choi SKY; Coyte PC
J Obstet Gynaecol Can; 2018 Mar; 40(3):317-327. PubMed ID: 29054509
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of Complete Salpingectomy Compared With Standard Postpartum Tubal Ligation at Cesarean Delivery: A Randomized Controlled Trial.
Subramaniam A; Blanchard CT; Erickson BK; Szychowski J; Leath CA; Biggio JR; Huh WK
Obstet Gynecol; 2018 Jul; 132(1):20-27. PubMed ID: 29889762
[TBL] [Abstract][Full Text] [Related]
16. Racial Disparities in Sterilization Procedure Performed at Time of Cesarean Section.
Walheim LK; Hong CX; Hamm RF
Am J Perinatol; 2024 May; 41(S 01):e934-e938. PubMed ID: 36351447
[TBL] [Abstract][Full Text] [Related]
17. Contraception and sterilization selection at delivery among pregnant patients with malignancy.
Harris CA; Mandelbaum RS; Rau AR; Song BB; Klar M; Ouzounian JG; Paulson RJ; Roman LD; Matsuo K
Acta Obstet Gynecol Scand; 2024 Apr; 103(4):695-706. PubMed ID: 37578024
[TBL] [Abstract][Full Text] [Related]
18. Utility of Vaginal Natural Orifice Transluminal Endoscopic Surgery for Permanent Sterilization after Failed Attempt at Bilateral Tubal Ligation at the Time of Previous Cesarean Section.
Hui M; Schwartzenburg C; Bhalwal A
J Minim Invasive Gynecol; 2022 Oct; 29(10):1138-1139. PubMed ID: 35863610
[TBL] [Abstract][Full Text] [Related]
19. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.
Madsen C; Baandrup L; Dehlendorff C; Kjaer SK
Acta Obstet Gynecol Scand; 2015 Jan; 94(1):86-94. PubMed ID: 25256594
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]